On Oct 30, major Wall Street analysts update their ratings for $Cemex (CX.US)$, with price targets ranging from $6 to $8.9.
J.P. Morgan analyst Adrian Huerta downgrades to a hold rating, and adjusts the target price from $7 to $6.
BofA Securities analyst Carlos Peyrelongue maintains with a hold rating.
Barclays analyst Benjamin Theurer maintains with a buy rating, and adjusts the target price from $9 to $8.
Scotiabank analyst Francisco Suarez Savin maintains with a buy rating, and adjusts the target price from $10 to $8.9.
Furthermore, according to the comprehensive report, the opinions of $Cemex (CX.US)$'s main analysts recently are as follows:
The company's Q4 results exhibited a softer performance with operating EBITDA registering at $747M, which was notably lower than anticipated. Nonetheless, it is believed that the majority of the adverse factors are already reflected in the current share price.
The company's recent quarterly performance fell short of the already cautious projections. There appears to be a lack of substantial fundamental drivers for the company's growth until at least mid-February, except for a possible upswing in the Mexican market. Moreover, expectations for the fourth-quarter outcomes are also leaning towards the milder side, accompanied by limited clarity regarding the next year's financial results. Current free cash flow generation does not suffice to support an increasing dividend and buybacks at a reasonable level.
Here are the latest investment ratings and price targets for $Cemex (CX.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月30日，多家華爾街大行更新了$西麥斯 (CX.US)$的評級，目標價介於6美元至8.9美元。
摩根大通分析師Adrian Huerta下調至持有評級，並將目標價從7美元下調至6美元。
美銀證券分析師Carlos Peyrelongue維持持有評級。
巴克萊銀行分析師Benjamin Theurer維持買入評級，並將目標價從9美元下調至8美元。
豐業銀行分析師Francisco Suarez Savin維持買入評級，並將目標價從10美元下調至8.9美元。
此外，綜合報道，$西麥斯 (CX.US)$近期主要分析師觀點如下：
公司Q4業績表現較爲疲軟，運營EBITDA達到了$74700萬，明顯低於預期。儘管如此，相信大多數不利因素已反映在當前股價中。
公司最近一個季度的表現未能達到已謹慎預測的水平。在至少到2月中旬之前，公司增長缺乏實質性的基本驅動因素，除了墨西哥市場可能出現的上升。此外，對第四季度業績的預期也更偏向於溫和一些，並且對明年的財務業績缺乏明確性。目前的自由現金流生成量不足以支持增加股息和回購股票的合理水平。
以下爲今日4位分析師對$西麥斯 (CX.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
